Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 17.22
-0.48 (-2.71%)
Sep 11, 2026, 3:04 PM CST
Hualan Biological Vaccine Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,187 | 1,203 | 1,128 | 2,410 | 1,826 | 1,830 |
Revenue Growth | 3.01% | 6.62% | -53.21% | 32.03% | -0.23% | -24.59% |
Gross Profit Gross Profit Growth | 853.46 | 877.36 | 841.03 | 2,028 | 1,456 | 1,476 |
Operating Income Operating Income Growth | 123.98 | 90.27 | 94.64 | 881.98 | 504.09 | 672.29 |
Net Income Net Income Growth | 198.57 | 182.92 | 205.52 | 859.97 | 519.63 | 620.97 |
Earnings Per Share EPS Growth | 0.33 | 0.31 | 0.34 | 1.43 | 0.88 | 1.15 |
EPS Growth | -1.33% | -10.54% | -75.93% | 62.20% | -23.46% | -32.86% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Flu vaccine Flu vaccine Growth | 1,199 | 1,123 | 2,407 | 1,818 | 1,825 |
Others Others Growth | 3.26 | 4.61 | 3.2 | 8.11 | 5.21 |
Total Total Growth | 1,203 | 1,128 | 2,410 | 1,826 | 1,830 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 2,151 | 2,785 | 3,227 | 2,613 | 2,149 | 957.39 |
Total Debt Total Debt Growth | - | - | 300.18 | 300.18 | 300.18 | 502.27 |
Net Cash (Debt) Net Cash Growth | 2,151 | 2,785 | 2,926 | 2,313 | 1,849 | 455.12 |
Net Cash Growth | -29.84% | -4.84% | 26.53% | 25.07% | 306.31% | -31.59% |
Net Cash Per Share Net Cash Per Share Growth | 3.61 | 4.68 | 4.89 | 3.84 | 3.13 | 0.84 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 417.36 | 357.13 | 468.04 | 888.02 | 288.66 | 569.33 |
Capital Expenditures CapEx Growth | -12.08 | -9.7 | -51.6 | -62.6 | -92.65 | -636.06 |
Free Cash Flow Free Cash Flow Growth | 405.28 | 347.43 | 416.45 | 825.42 | 196.01 | -66.73 |
Free Cash Flow Growth | 36.74% | -16.57% | -49.55% | 321.10% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 71.91% | 72.96% | 74.57% | 84.15% | 79.78% | 80.65% |
Operating Margin | 10.45% | 7.51% | 8.39% | 36.59% | 27.61% | 36.74% |
Pretax Margin | 17.86% | 15.62% | 19.02% | 41.77% | 32.29% | 38.57% |
Profit Margin | 16.73% | 15.21% | 18.22% | 35.68% | 28.46% | 33.94% |
FCF Margin | 34.14% | 28.89% | 36.93% | 34.24% | 10.74% | -3.65% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.600 | 1.400 | 0.200 | 0.600 | 0.200 | 0.133 |
Dividend Per Share Growth | 600.00% | 600.00% | -66.67% | 200.00% | 50.04% | - |
Dividend Yield | 9.29% | 7.87% | 1.25% | 2.43% | 0.76% | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 51.66 | 60.60 | 50.69 | 19.40 | 34.32 | - |
Forward PE | 47.83 | 7.75 | 9.86 | 15.22 | 17.00 | - |
P/FCF Ratio | 25.28 | 31.91 | 25.02 | 20.21 | 90.98 | - |
PS Ratio | 8.63 | 9.22 | 9.24 | 6.92 | 9.77 | - |